MacroGenics stake held by Bank of America at 4.0%

Bank of America Corporation filed an amended Schedule 13G reporting beneficial ownership of 2,556,475 shares of MacroGenics, Inc. common stock.

Rhea-AI Filing Summary

Bank of America Corporation filed an amended Schedule 13G reporting beneficial ownership of 2,556,475 shares of MacroGenics, Inc. common stock. This represents 4.0% of the class, based on 63,563,123 shares outstanding as of May 8, 2026, from MacroGenics’ May 13, 2026 Form 10-Q.

Bank of America reports no sole voting or dispositive power and shared voting and dispositive power over all 2,556,475 shares, held through wholly owned subsidiaries including BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, and BofA Securities Europe SA. The filing confirms ownership of 5 percent or less of the class.

Key Figures

Beneficially owned shares: 2,556,475 shares Percent of class: 4.0% Shares outstanding baseline: 63,563,123 shares +4 more

7 metrics

Beneficially owned shares 2,556,475 shares MacroGenics common stock beneficially owned by Bank of America

Percent of class 4.0% Portion of MacroGenics common stock class owned by Bank of America

Shares outstanding baseline 63,563,123 shares MacroGenics shares outstanding as of May 8, 2026 from May 13, 2026 Form 10-Q

Sole voting power 0 shares Shares over which Bank of America has sole voting power

Shared voting power 2,556,475 shares Shares over which Bank of America has shared voting power

Sole dispositive power 0 shares Shares over which Bank of America has sole dispositive power

Shared dispositive power 2,556,475 shares Shares over which Bank of America has shared dispositive power

Key Terms

beneficial ownership, shared voting power, shared dispositive power, Schedule 13G, +1 more

5 terms

beneficial ownership financial

"The beneficial ownership calculation relies on the 63,563,123 outstanding shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared voting power financial

"Shared Voting Power 2,556,475.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 2,556,475.00"

Schedule 13G regulatory

"This statement on is being filed by Bank of America Corporation"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

parent holding company regulatory

"If a parent holding company has filed this schedule, pursuant to (ii)(G)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of MacroGenics (MGNX) does Bank of America report owning in this Schedule 13G/A?

Bank of America reports beneficial ownership of 4.0% of MacroGenics common stock. This is based on 2,556,475 shares owned versus 63,563,123 shares outstanding as of May 8, 2026, cited from MacroGenics’ May 13, 2026 Form 10-Q.

How many MacroGenics (MGNX) shares does Bank of America beneficially own?

Bank of America reports beneficial ownership of 2,556,475 shares of MacroGenics common stock. These shares are held with shared voting and dispositive power through several wholly owned subsidiaries, including BofA Securities, Inc. and Bank of America N.A.

Does Bank of America have sole or shared voting power over its MacroGenics (MGNX) shares?

Bank of America reports 0 shares with sole voting power and 2,556,475 shares with shared voting power. It likewise reports 0 shares with sole dispositive power and 2,556,475 shares with shared dispositive power over MacroGenics common stock.

What share count did Bank of America use to calculate its 4.0% MacroGenics (MGNX) ownership?

The 4.0% beneficial ownership is calculated using 63,563,123 MacroGenics shares outstanding. This outstanding share figure comes from MacroGenics’ Form 10-Q filed May 13, 2026, which reports totals as of May 8, 2026.

Which Bank of America subsidiaries hold the MacroGenics (MGNX) position reported on this Schedule 13G/A?

The statement is filed by Bank of America on behalf of itself and wholly owned subsidiaries including BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, and BofA Securities Europe SA, each classified under applicable Exchange Act provisions.

Does Bank of America report owning more than 5% of MacroGenics (MGNX)?

No. Bank of America explicitly reports ownership of 5 percent or less of MacroGenics’ common stock. The filing states a 4.0% beneficial ownership based on 2,556,475 shares versus 63,563,123 outstanding shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:18 PM Accepted by SEC EDGAR 08/03/2026 - 04:18 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

MACROGENICS INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

556099109

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 556099109

1

Names of Reporting Persons

BANK OF AMERICA CORP /DE/

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,556,475.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,556,475.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,556,475.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.0 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: The beneficial ownership calculation relies on the 63,563,123 outstanding shares disclosed in the Form 10-Q by the issuer on May 13, 2026, which reports share totals as of May 8, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MACROGENICS INC
(b)	Address of issuer's principal executive offices: 9704 MEDICAL CENTER DRIVE, 9704 MEDICAL CENTER DRIVE, Rockville, MARYLAND, 20850
Item 2.
(a)	Name of person filing: BANK OF AMERICA CORP /DE/
(b)	Address or principal business office or, if none, residence: 100 N TRYON ST CHARLOTTE, NC 28255
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 556099109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,556,475.00
(b)	Percent of class: 4.0%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0.00
	(ii) Shared power to vote or to direct the vote: 2,556,475.00
	(iii) Sole power to dispose or to direct the disposition of: 0.00
	(iv) Shared power to dispose or to direct the disposition of: 2,556,475.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. This statement on Schedule 13G is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); Bank of America N.A., a bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); Merrill Lynch International, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J); and BofA Securities Europe SA, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J).
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BANK OF AMERICA CORP /DE/

Signature:	/s/ Monica Yako
Name/Title:	Authorized Signatory
Date:	08/03/2026